75706-12-6 Leflunomide AKSci J40005
 
 
Loading Please Wait...
  J40005    AKSci Reference Standard
Leflunomide
, 99% (HPLC), powder
 
5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)




IDENTITY
CAS Number:75706-12-6
MDL Number:MFCD00867593
MF:C12H9F3N2O2
MW:270.21
BRN:4323174
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:99% (HPLC), powder
Physical Form (at 20°C):Solid
Melting Point:164-170°C
Density:1.392
Refractive Index:1.541
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
UN #:UN2811
Hazard Class:6.1; Poison
Packing Group:III
A hazmat fee may apply depending on the amount ordered, as indicated in the list of package sizes.

BIOLOGICAL INFO
Application(s):An inhibitor of Cox-2 and tyrosine kinase

REVIEW

 Leflunomide is an immunosuppressive drug that inhibits T and B cell responses. Leflunomide is an inhibitor of Cox-2, of tyrosine phosphorylation (tyrosine kinase), of DHODH (dihydroorotate dehydrogenase), an enzyme for de novo pyrimidine synthesis, and of TNF-dependent NF-κB activation. The physiological activity of leflunomide is attributed mainly to its metabolite.

REFERENCES
[1]Bartlett, R.R., et al. 1985. Int. J. Immunopharmacol. 7: 7-18. PMID: 3873420
[2] Bartlett, R.R., et al. 1991. Agents Actions 32: 10-21. PMID: 2058454
[3] Mattar, T., et al. 1993. FEBS Lett. 334: 161-164. PMID: 8224241
[4] Xu, X., et al. 1995. J. Biol. Chem. 270: 12398-12403. PMID: 7759480

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Danger

Hazard Statements
H301; H315; H319; H335

Precautionary Statements
P261; P264; P270; P271; P280; P301+P310; P302+P352; P304+P340; P305+P351+P338; P312; P321; P330; P332+P313; P337+P313; P362; P403+P233; P405; P501


Current as of October 1, 2023

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS Request COA

⚠️
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise. They are not sold to individuals. Additional restrictions may apply.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.



CATEGORIES

 APIs and Bioactives > Pyrimidine Synthesis Inhibitors


PubChem